Search results for "SYNDROME CORONAVIRUS"

showing 10 items of 552 documents

Visual abstract for Abdominal Radiology: what it is, why we need it and how to make it

2021

Visual abstract for Abdominal Radiology: what it is, why we need it and how to make it

Radiography Abdominalmedicine.medical_specialty2019-20 coronavirus outbreakRadiological and Ultrasound TechnologyCoronavirus disease 2019 (COVID-19)business.industryUrologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GastroenterologyHepatologymedicine.diseaseEditorialInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingMedical emergencyVisual abstractRadiologybusinessAbdominal Radiology
researchProduct

Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR

2020

ABSTRACTSystematic testing of large population groups by RT-PCR is mandatory to Covid-19 case identification and contact tracing in order to minimize the likelyhood of resurgence in contagion. Sample pooling for RT-PCR has been effectively used to detect community transmission of SARS CoV-2. Nevertheless, this procedure may decrease the sensitivity of RT-PCR assays due to specimen dilution. We evaluated the efficacy of this strategy for diagnosis of Covid-19 using a sensitive commercially-available RT-PCR targeting SARS CoV-2 E and RdRp genes in a single reaction. A total of 20 mini-pools containing either 5 (n=10) or 10 (n=10) nasopharyngeal exudates collected in universal transport medium…

Real-time polymerase chain reactionCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PoolingLarge populationBiologyVirologyContact tracingCase identificationSystematic testing
researchProduct

Socio-Demographic Factors Involved in a Low-Incidence Phase of SARS-CoV-2 Spread in Sicily, Italy

2021

Background: The present study analysed SARS-CoV-2 cases observed in Sicily and investigated social determinants that could have an impact on the virus spread. Methods: SARS-CoV-2 cases observed among Sicilian residents between the 1 February 2020 and 15 October 2020 have been included in the analyses. Age, sex, date of infection detection, residency, clinical outcomes, and exposure route have been evaluated. Each case has been linked to the census section of residency and its socio-demographic data. Results: A total of 10,114 patients (202.3 cases per 100,000 residents

Reduced riskLeadership and ManagementSocio demographicsmedia_common.quotation_subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmigrationHealth InformaticsoutcomesAsymptomaticArticleCensus section Outcomes SARS-CoV-2 Socio-demographic factors03 medical and health sciences0302 clinical medicineHealth Information Managementsocio-demographic factorsMedicine030212 general & internal medicineSocial determinants of healthmedia_commonbusiness.industrySARS-CoV-2Health PolicyIncidence (epidemiology)RCensuscensus section030220 oncology & carcinogenesisMedicinemedicine.symptombusinessDemographyHealthcare
researchProduct

Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry

2021

Abstract Background Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID‐19) pandemic. Methods A national registry, named DA‐COVID‐19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID‐19 pandemic on the management of adult AD patients treated with systemic immunomodulant/immunosuppressive medications or phototherapy. Demographic and clinical data were obtained at different timepoints by teledermatology during COVID‐19 pandemic, when regular visits were not allowed due to sanitary restrictions. Disease severi…

Registrie0301 basic medicineDermatitisSystemic therapy0302 clinical medicinePandemicImmunology and AllergyMedicineRegistriesatopic dermatitis; COVID; SARS‐ CoVCOVIDtreatmentatopic dermatitisatopic dermatitis; COVID; SARS-CoVSARS-CoVAtopic dermatitisDupilumabSARS‐ CoVItalyOriginal ArticleSettore MED/35 - MALATTIE CUTANEE E VENEREEHumanatopic dermatitiAdultmedicine.medical_specialtyTeledermatologyCOVID; SARS‐CoV; atopic dermatitis treatmentCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCOVID; SARS‐CoV; atopic dermatitis; Adult; Communicable Disease Control; Humans; Italy; Pandemics; Registries; SARS-CoV-2; COVID-19; Dermatitis AtopicAtopicDermatitis Atopic03 medical and health sciencesSettore MED/35Disease severityInternal medicineatopic dermatitis treatmentHumansPandemicsPandemicbusiness.industrySARS-CoV-2SARS‐CoVCOVID-19medicine.disease030104 developmental biology030228 respiratory systemCommunicable Disease Controlatopic dermatitis; COVID; SARS-CoV; Adult; Communicable Disease Control; Humans; Italy; Pandemics; Registries; SARS-CoV-2; COVID-19; Dermatitis Atopicatopic dermatitis COVID SARS-CoVbusiness
researchProduct

Risk perception of sars-cov-2 infection and implementation of various protective measures by dentists across various countries

2021

Objective: Healthcare workers in general are at a high risk of potential infections with COVID-19, especially those who work with aerosol generating procedures. Dentists fall in this category, as not only do they operate with aerosol generating procedures but also operate within a face-to-face contact area. Methods: A structured self-administered questionnaire was developed at Najran University and provided to the participants for data collection. The data collected included information on risk perception and incorporation of measures for protection against COVID-19 to gauge the attitude of dentists during this period. Also, clinical implementation of various protective measures was reviewe…

Riskmedicine.medical_specialtyHealth Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DentistsArticle03 medical and health sciences0302 clinical medicineHEPASurveys and QuestionnairesHealth caremedicineInfection controlHumans030212 general & internal medicineData collectionbusiness.industrySARS-CoV-2Risk of infectionPublic Health Environmental and Occupational HealthRCOVID-19030206 dentistryRisk perceptionProtectiveSterilization (medicine)Family medicineMedicineRNA ViralPerceptionbusinessInfection
researchProduct

SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole …

2021

(1) Background: Detection of asymptomatic or subclinical human coronavirus SARS-CoV-2 infection in healthcare workers (HCWs) is crucial for understanding the overall prevalence of the new coronavirus and its infection potential in public (non-infectious) healthcare units with emergency wards. (2) Methods: We evaluated the host serologic responses, measured with semi-quantitative ELISA tests (IgA, IgG, IgM abs) in sera of 90 individuals in Hospital no. 4 in Bytom, 84 HCWs in the University Hospital in Opole and 25 in a Miasteczko Śląskie local surgery. All volunteers had negative RT-PCR test results or had not had the RT-PCR test performed within 30 days before sampling. The ELISA test was m…

SARS-CoV-2; COVID-19; RT-PCR; asymptomatic; health-care professionals; serological surveillance; antibody screening; immunoglobulinsmedicine.medical_specialtyHealth PersonnelHealth Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)serological surveillanceimmunoglobulinsRT-PCRAsymptomaticArticleantibody screeningSerology03 medical and health sciences0302 clinical medicineInternal medicineHealth caremedicineHumansasymptomaticProspective Studies030212 general & internal medicineProspective cohort study030304 developmental biologySubclinical infection0303 health scienceshealth-care professionalsbusiness.industrySARS-CoV-2Public Health Environmental and Occupational HealthRCOVID-19virus diseasesMedicinePolandmedicine.symptombusinessNon infectiousAntibody screeningInternational Journal of Environmental Research and Public Health; Volume 18; Issue 8; Pages: 4376
researchProduct

The relationship between fear of COVID-19 and intention to get vaccinated. The serial mediation roles of existential anxiety and conspiracy beliefs

2021

Abstract Today, we witness the progress toward global COVID-19 vaccinations organized by countries worldwide. Experts say a mass vaccination plan is the only effective antidote against the spread of SARS-COV-2. However, a part of the world population refuses vaccination. The present study aimed to understand the impact of some individual variables on the intention to get vaccinated. Through a serial mediation model, we tested the influence of fear of COVID-19 on the intention to get vaccinated and the serial mediating effect of existential anxiety and conspiracy beliefs. Via a cross-sectional design this research was conducted with the participation of 223 French adults (Female: 69.5%; Male…

Settore M-PSI/01 - Psicologia GeneraleCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Fear of COVID-19World populationmedicine.diseaseIntention to get vaccinatedWitnessArticleVaccinationConspiracy beliefsDeath anxietymedicineExistential anxietyPsychologyConspiracy beliefs Existential anxiety Fear of COVID-19 Intention to get vaccinatedSocial psychologyGeneral PsychologyExistential anxietySerial mediationPersonality and Individual Differences
researchProduct

Diffusion modeling of COVID-19 under lockdown

2021

Viral immune evasion by sequence variation is a significant barrier to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine design and coronavirus disease-2019 diffusion under lockdown are unpredictable with subsequent waves. Our group has developed a computational model rooted in physics to address this challenge, aiming to predict the fitness landscape of SARS-CoV-2 diffusion using a variant of the bidimensional Ising model (2DIMV) connected seasonally. The 2DIMV works in a closed system composed of limited interaction subjects and conditioned by only temperature changes. Markov chain Monte Carlo method shows that an increase in temperature implicates reduced virus diffusi…

Settore MED/17 - Malattie InfettiveCoronavirus disease 2019 (COVID-19)Fitness landscapeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesComputational Mechanicsmedicine.disease_cause01 natural sciencesSettore MED/01 - Statistica Medica010305 fluids & plasmassymbols.namesakeARTICLES0103 physical sciencesmedicineStatistical physicsDiffusion (business)010306 general physicsCoronavirusFluid Flow and Transfer ProcessesPhysicsDiffusion modelingBiofluid MechanicsMechanical EngineeringMarkov chain Monte CarloCondensed Matter PhysicsDiffusion modeling COVI 19Mechanics of MaterialssymbolsIsing modelPhysics of Fluids
researchProduct

Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS‐CoV‐2 neutralizing activity of sera

2020

Purpose: Assessment of commercial SARS-CoV-2 immunoassays for their capacity to provide reliable information on sera neutralizing activity is an emerging need. We evaluated the performance of two commercially-available lateral flow immunochromatographic assays (LFIC) (Wondfo SARS-CoV-2 Antibody test and the INNOVITA 2019-nCoV Ab test) in comparison with a SARS-CoV-2 neutralization pseudotyped assay for COVID-19 diagnosis in hospitalized patients, and investigate whether the intensity of the test band in LFIC associates with neutralizing antibody (NtAb) titers. Patients and Methods: Ninety sera were included from 51 patients with moderate to severe COVID-19. A green fluorescent protein (GFP)…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Green Fluorescent ProteinsAntibodies ViralNeutralizing antibodiesNeutralizationSARS‐CoV‐2Green fluorescent protein03 medical and health sciencesCOVID-19 Testing0302 clinical medicineCOVID‐19VirologyLateral flow 16 immunochromatographic assaysHumansMedicineImmunochromatographic Assays030212 general & internal medicineNeutralizing antibodyResearch ArticlesImmunoassaybiologybusiness.industrySARS-CoV-2COVID-19biology.organism_classificationAntibodies NeutralizingVirologyTiterInfectious DiseasesImmunoglobulin MVesicular stomatitis virusImmunoglobulin GSpike Glycoprotein Coronavirusbiology.proteinlateral flow immunochromatographic assays030211 gastroenterology & hepatologyLteral flow immunochromatographic assaysAntibodybusinessResearch Article
researchProduct

Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.

2020

Viruses can generate molecular mimicry phenomena within their hosts. Why shouldsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) not be considered one of these?Information in this short review suggests that it might be so and, thus, encourages research aimingat testing this possibility. We propose, as a working hypothesis, that the virus induces antibodiesand that some of them crossreact with host’s antigens, thus eliciting autoimmune phenomena withdevasting consequences in various tissues and organs. If confirmed, by in vitro and in vivo tests,this could drive researchers to find effective treatments against the virus.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesantistress proteinslcsh:Medicinecrossreactive antibodiesWorking hypothesismedicine.disease_causeIn vivo testsViruscell stre03 medical and health sciences0302 clinical medicinecell stressAntigenmedicinemolecular mimicry030304 developmental biologyantistress protein0303 health sciencesbiologybusiness.industrySARS-CoV-2lcsh:Rmolecular chaperonesCOVID-19General Medicinemolecular chaperoneIn vitroMolecular mimicryImmunologybiology.proteinCommentaryAntibodybusiness030217 neurology & neurosurgeryJournal of clinical medicine
researchProduct